Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance Study of BIA 28-6156 in Healthy Men
NCT05220072Phase 1Completed
- Sponsor
- BIAL
- Start
- Aug 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pariceract in Parkinson's disease (PD), sponsored by BIAL. Primary endpoints: Mass balance recovery of total radioactivity in all excreta at Day 11, Collection of urine and faecal samples for total radioactivity and 1 more. Started Aug 2021; status: completed.
02
Drugs
pariceract
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05220072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05220072.